NeuRizer Valuation

Is NRZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NRZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NRZ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NRZ's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NRZ?

Key metric: As NRZ is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for NRZ. This is calculated by dividing NRZ's market cap by their current book value.
What is NRZ's PB Ratio?
PB Ratio	0.09x
Book	AU$73.02m
Market Cap	AU$8.72m

NRZ key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	-3.7x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does NRZ's PB Ratio compare to its peers?

The above table shows the PB ratio for NRZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	6.8x
BGT Bio-Gene Technology	2.6x	n/a	AU$7.2m
TGH Terragen Holdings	2.5x	n/a	AU$14.8m
FTZ Fertoz	0.5x	n/a	AU$5.3m
TMG Trigg Minerals	21.5x	n/a	AU$23.8m
NRZ NeuRizer	0.09x	n/a	AU$8.7m

Price-To-Book vs Peers: NRZ is good value based on its Price-To-Book Ratio (0.1x) compared to the peer average (6.8x).

Price to Book Ratio vs Industry

How does NRZ's PB Ratio compare vs other companies in the AU Chemicals Industry?

1 Company	Price / Book	Estimated Growth	Market Cap
Industry Avg.	1.8x	34.7%
NRZ NeuRizer	0.09x	n/a	US$5.70m

No more companies available in this PB range

1 Company		Estimated Growth	Market Cap
Industry Avg.	1.8x	34.7%
NRZ NeuRizer	0.09x	n/a	US$5.70m

No more companies

Price-To-Book vs Industry: NRZ is good value based on its Price-To-Book Ratio (0.1x) compared to the Australian Chemicals industry average (1.8x).

Price to Book Ratio vs Fair Ratio

What is NRZ's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NRZ PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	0.09x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate NRZ's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Capral

AU$156.9m

Manufactures, markets, and distributes fabricated and semi-fabricated aluminum related products in Australia.

CAA

AU$9.28

-0.7%

5.9%

Incitec Pivot

AU$6.0b

Manufactures and distributes industrial explosives, industrial chemicals, and fertilizers in Australia, the United States, and internationally.

IPL

AU$3.20

5.8%

12.9%

Aurelia Metals

AU$296.0m

Engages in the exploration and production of mineral properties in Australia.

AMI

AU$0.17

3.0%

47.8%